Medication injection device

Ahlgrim , et al. October 25, 2

Patent Grant D770038

U.S. patent number D770,038 [Application Number D/495,028] was granted by the patent office on 2016-10-25 for medication injection device. This patent grant is currently assigned to Eli Lilly and Company. The grantee listed for this patent is Eli Lilly and Company. Invention is credited to Dirk Ahlgrim, Gen Suzuki.


United States Patent D770,038
Ahlgrim ,   et al. October 25, 2016

Medication injection device

Claims

CLAIM The ornamental design for a medication injection device, as shown and described.
Inventors: Ahlgrim; Dirk (Boston, MA), Suzuki; Gen (Kanagawa, JP)
Applicant:
Name City State Country Type

Eli Lilly and Company

Indianapolis

IN

US
Assignee: Eli Lilly and Company (Indianapolis, IN)
Appl. No.: D/495,028
Filed: June 26, 2014

Current U.S. Class: D24/113
Current International Class: 2402
Field of Search: ;D24/112-114,108,133,130,127,186 ;606/181,185 ;604/264,272,187,181,184,227

References Cited [Referenced By]

U.S. Patent Documents
1617140 February 1927 Alland
D160436 October 1950 Seibert
D303020 August 1989 Reichmann
4973318 November 1990 Holm et al.
5042977 August 1991 Bechtold et al.
D328611 August 1992 Longarzo
D330079 October 1992 Dalling et al.
5226895 July 1993 Harris
5226896 July 1993 Harris
5279586 January 1994 Balkwill
5383865 January 1995 Michel
5545147 August 1996 Harris
5626566 May 1997 Petersen et al.
5645534 July 1997 Chanoch
5674204 October 1997 Chanoch
5688251 November 1997 Chanoch
5820602 October 1998 Kovelman et al.
5921966 July 1999 Bendek et al.
5925021 July 1999 Castellano et al.
5957896 September 1999 Bendek et al.
6001089 December 1999 Burroughs et al.
6004297 December 1999 Steenfeldt-Jensen et al.
6048336 April 2000 Gabriel
D426299 June 2000 Bydlon et al.
6193698 February 2001 Kirchhofer et al.
6221046 April 2001 Burroughs et al.
6277099 August 2001 Strowe et al.
D462760 September 2002 Ahlgrim
D479599 September 2003 Bainton
D479600 September 2003 Bainton
D479601 September 2003 Tyce
D479602 September 2003 Bainton
D479603 September 2003 Tyce
D479747 September 2003 Bainton
D479748 September 2003 Tyce
D492027 June 2004 Tyce et al.
D492405 June 2004 Bainton
D499485 December 2004 Tyce
D501253 January 2005 Bainton
D503797 April 2005 Tyce
D505490 May 2005 Tyce
D540465 April 2007 Bainton
7241278 July 2007 Moller
7291132 November 2007 DeRuntz et al.
D567938 April 2008 Shinohara
D567939 April 2008 Mattigka
D598539 August 2009 Tyce
D599008 August 2009 Tyce
D599009 August 2009 Tyce
D599010 August 2009 Tyce
D599011 August 2009 Tyce
D600794 September 2009 Tyce
D600795 September 2009 Tyce
D606649 December 2009 Tyce
D606650 December 2009 Tyce
D608442 January 2010 Tyce
D610251 February 2010 Tyce
D610252 February 2010 Tyce
D610676 February 2010 Tyce
D610677 February 2010 Tyce
D621500 August 2010 Sanders et al.
D626216 October 2010 Tyce
D641077 July 2011 Sanders et al.
D651305 December 2011 Hawley et al.
D652136 January 2012 Hawley et al.
D685464 July 2013 Sanders
D687544 August 2013 Stephan et al.
8556864 October 2013 Veasey et al.
8603044 December 2013 Veasey et al.
D697617 January 2014 Sanders
D703314 April 2014 Schneider
D703315 April 2014 Sanders
D703316 April 2014 Sanders
D703809 April 2014 Sanders
D703810 April 2014 Sanders
D716442 October 2014 Magome
D717428 November 2014 Sendatzki et al.
D717940 November 2014 Magome
D719257 December 2014 Magome et al.
D722158 February 2015 Magome et al.
D724721 March 2015 Geert-Jensen
D725771 March 2015 Sendatzki
D734450 July 2015 Geert-Jensen
Foreign Patent Documents
0937472 Aug 1999 EP
1095668 May 2001 EP
9810814 Mar 1998 WO
9943283 Sep 1999 WO
0110484 Feb 2001 WO
02092153 Nov 2002 WO

Other References

HumaPen.RTM. Savvio.TM. card, Eli Lilly and Company, 2013. cited by applicant .
Humalog.RTM. Brochure, Eli Lilly and Company, 2014. cited by applicant .
United HealthCare Formulary Sheet, Eli Lilly and Company, 2014. cited by applicant .
NovoLog.RTM. Mix 70/30 FlexPen.RTM. Brochure, Novo Nordisk, 2013. cited by applicant .
Forteo.RTM. User Manual, Eli Lilly and Company, 2011. cited by applicant .
HumatroPen.RTM. 12 mg User Manual, Eli Lilly and Company, 2012. cited by applicant .
Levemir.RTM. FlexTouch.RTM. Brochure, 2014. cited by applicant .
Norditropin.RTM. FlexPro.RTM. 5mg, 10mg, and 15mg leaflet, Novo Nordisk, 2011. cited by applicant .
NovoPen.RTM. 4 User Manual, Novo Nordisk, 2009. cited by applicant .
NovoPen.RTM. 5 Quick Guide, Novo Nordisk , 2012. cited by applicant .
NovoPen Echo.RTM. Quick Guide, Novo Nordisk, 2013. cited by applicant .
Victoza.RTM. Instructions For Use, Novo Nordisk, 2015. cited by applicant .
KwikPen.TM. Pocket Guide, Eli Lilly and Company, 2013. cited by applicant .
NovoPen.RTM. 3 Brochure, Novo Nordisk, 1999. cited by applicant .
Brochure in Japanese, Eli Lilly and Company, 1999. cited by applicant .
Innovo.RTM. Brochure, Novo Nordisk, 2000. cited by applicant .
OptiClik.TM. Instruction Leaflet, Aventis. cited by applicant .
Lantus OptiSet Brochure, Aventis. cited by applicant .
TactiPen.RTM. Patient Brochure, Sanofi. cited by applicant .
NovoLet.RTM. Brochure, Novo Nordisk. cited by applicant .
Die OptiPen.RTM. Familie Brochure, Aventis. cited by applicant .
InnoLet.RTM. Brochure, Novo Nordisk. cited by applicant.

Primary Examiner: Muller; David
Attorney, Agent or Firm: Prein; Edward J.

Description



FIG. 1 is a perspective view of a medication injection device showing our new design;

FIG. 2 is a front view thereof;

FIG. 3 is a top view thereof;

FIG. 4 is bottom view thereof;

FIG. 5 is a side view thereof;

FIG. 6 is an opposite side view thereof; and,

FIG. 7 is a rear view thereof.

The cross-hatched annular region of the button in FIGS. 1 and 4 represents a contrasting color region visible on the button that forms part of the claimed design. The dash lines in FIGS. 1, 2 and 4 show a bottom portion and surround a front portion of the device which form no part of the claimed design.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed